AIRLINK 72.59 Increased By ▲ 3.39 (4.9%)
BOP 4.99 Increased By ▲ 0.09 (1.84%)
CNERGY 4.29 Increased By ▲ 0.03 (0.7%)
DFML 31.71 Increased By ▲ 0.46 (1.47%)
DGKC 80.90 Increased By ▲ 3.65 (4.72%)
FCCL 21.42 Increased By ▲ 1.42 (7.1%)
FFBL 35.19 Increased By ▲ 0.19 (0.54%)
FFL 9.33 Increased By ▲ 0.21 (2.3%)
GGL 9.82 Increased By ▲ 0.02 (0.2%)
HBL 112.40 Decreased By ▼ -0.36 (-0.32%)
HUBC 136.50 Increased By ▲ 3.46 (2.6%)
HUMNL 7.14 Increased By ▲ 0.19 (2.73%)
KEL 4.35 Increased By ▲ 0.12 (2.84%)
KOSM 4.35 Increased By ▲ 0.10 (2.35%)
MLCF 37.67 Increased By ▲ 1.07 (2.92%)
OGDC 137.75 Increased By ▲ 4.88 (3.67%)
PAEL 23.41 Increased By ▲ 0.77 (3.4%)
PIAA 24.55 Increased By ▲ 0.35 (1.45%)
PIBTL 6.63 Increased By ▲ 0.17 (2.63%)
PPL 125.05 Increased By ▲ 8.75 (7.52%)
PRL 26.99 Increased By ▲ 1.09 (4.21%)
PTC 13.32 Increased By ▲ 0.24 (1.83%)
SEARL 52.70 Increased By ▲ 0.70 (1.35%)
SNGP 70.80 Increased By ▲ 3.20 (4.73%)
SSGC 10.54 No Change ▼ 0.00 (0%)
TELE 8.33 Increased By ▲ 0.05 (0.6%)
TPLP 10.95 Increased By ▲ 0.15 (1.39%)
TRG 60.60 Increased By ▲ 1.31 (2.21%)
UNITY 25.10 Decreased By ▼ -0.03 (-0.12%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 7,546 Increased By 137.4 (1.85%)
BR30 24,809 Increased By 772.4 (3.21%)
KSE100 71,902 Increased By 1235.2 (1.75%)
KSE30 23,595 Increased By 371 (1.6%)
World

Bangladesh to begin COVID-19 vaccinations next month

  • The South Asian country of more than 160 million in November signed a deal with the Serum Institute of India to buy 30 million doses of the vaccine developed by British drugmaker AstraZeneca.
  • The vaccine will be first applied on the health workers and it will be monitored for the next seven days. After that, we'll begin the vaccination across the country in the first week of February.
Published January 11, 2021

DHAKA: Bangladesh will begin inoculating people against COVID-19 in the first week of February as it hopes to get the vaccine by end of this month, a senior health ministry official said on Monday.

The South Asian country of more than 160 million in November signed a deal with the Serum Institute of India to buy 30 million doses of the vaccine developed by British drugmaker AstraZeneca.

The vaccine will arrive in the country by Jan. 25, Abul Bashar Mohammed Khurshid Alam, head of the Directorate General of Health Services, told a news conference.

"The vaccine will be first applied on the health workers and it will be monitored for the next seven days. After that, we'll begin the vaccination across the country in the first week of February," he said.

Frontline workers like health service providers and police will be given priority, health ministry officials said.

Bangladesh, with patchy healthcare facilities, has 523,302 confirmed cases, including 7,803 deaths.

In the global race to develop vaccines against COVID-19, AstraZeneca's candidate is viewed as offering one of the best hopes for many developing countries because of its cheaper price and ability to be transported at normal fridge temperatures.

The Serum Institute, the world's largest manufacturer of vaccines by volume, has partnered with AstraZeneca, the Gates Foundation and the Gavi vaccine alliance to produce more than a billion doses of a COVID-19 vaccine for global supply.

Bangladesh will also get 68 million doses of vaccine from the GAVI vaccine alliance, Health Secretary Abdul Mannan said last month, referring to the global health partnership set up in 2000 to increase access to immunisation in poor countries.

Comments

Comments are closed.